Status:
COMPLETED
Application of Simethicone in Esophagogastroscopy
Lead Sponsor:
Affiliated Hospital to Academy of Military Medical Sciences
Conditions:
Gastric Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This is a randomized controlled trial to comparing the different simethicone administration strategies for esophagogastroscopy. Recent studies have indicated that the administration of simethicone bef...
Detailed Description
Esophagogastroscopy can enable the direct examination of the esophageal and gastric mucosal lesions, which has been widely applied in clinical practice. However, during the examination, too much water...
Eligibility Criteria
Inclusion
- Above 18 years old patients
- Who agree to participate in the study
- Patients with the indications for gastroduodenoscopy
Exclusion
- Patients, who were receiving nonsteroidal anti-inflammatory drugs, pump inhibitors (PPI) or antibiotics in the last 3 weeks.
- Severe uncontrolled coagulopathy
- Prior history of gastric surgery.
- Pregnancy and lactation
Key Trial Info
Start Date :
May 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 31 2019
Estimated Enrollment :
311 Patients enrolled
Trial Details
Trial ID
NCT03776916
Start Date
May 1 2019
End Date
August 31 2019
Last Update
September 20 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
PLA General Hospital
Beijing, Beijing Municipality, China, 100071